Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/1998
06/25/1998WO1998026776A1 Method for treating renal failure
06/25/1998CA2275256A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/24/1998EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72
06/24/1998EP0849266A1 Novel polymorphic form of doxazosin mesylate (form III)
06/24/1998EP0849265A1 Novel polymorphic form of doxazosin mesylate (form II)
06/24/1998EP0849264A1 Novel polymorphic form of doxazosin mesylate (form I)
06/24/1998CN1185736A Use of thiazolium compounds for preventing and preverting the formation of advanced glycosylation endproducts
06/23/1998US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with
06/23/1998US5770610 Melatonin agonists for use in the treatment of benign prostatic hyperplasia (BPH)
06/23/1998US5770571 Method and agents for inhibiting protein aging
06/23/1998US5770209 Acceleration of wound healing using connective tissue growth factor
06/23/1998CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
06/23/1998CA1339924C 11beta-phenyl-14betha steroids
06/20/1998CA2224916A1 New polymorphous form of doxazosine mesylate (form 1)
06/20/1998CA2224884A1 New polymorphous form of doxazosine mesylate (form 11)
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998025895A1 Inhibitors of the enzymatic activity of psa
06/18/1998WO1998018430A3 P2y receptor antagonists
06/18/1998CA2274958A1 Inhibitors of the enzymatic activity of psa
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/17/1998EP0848060A2 Novel human 11CB splice variant
06/17/1998CN1185112A Use of flavanolignanes for the prepn. of medicametns with antiproliferative activity in uterus, ovary and breast
06/17/1998CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism
06/16/1998US5767274 Treating tumors or restenosis
06/16/1998US5767251 Polypeptides
06/16/1998US5767139 Skin disorders; alopecia; prostate cancer
06/16/1998US5767116 Bicyclic aromatic compounds as therapeutic agents
06/16/1998US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same
06/11/1998WO1998024905A2 Secreted proteins and polynucleotides encoding them
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein
06/11/1998WO1998024791A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
06/11/1998WO1998024790A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
06/11/1998WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity
06/11/1998WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
06/11/1998WO1998024762A1 Vitamin d3 derivatives
06/11/1998WO1998024465A1 Wound healing and treatment of fibrosis
06/11/1998CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274002A1 Wound healing and treatment of fibrosis
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2272330A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
06/11/1998CA2272148A1 Vitamin d3 derivatives
06/11/1998CA2271072A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
06/10/1998EP0674508B1 4-guanidinobutyramide for improving blood circulation
06/10/1998CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763458 1-phenylalkanone 5-HT4 receptor ligands
06/09/1998US5763448 Schizophrenia
06/09/1998US5763429 Method of treating prostatic diseases using active vitamin D analogues
06/09/1998US5763420 Method for modulating the immune system
06/09/1998US5763399 Revitalizing tissues with growth factor
06/09/1998US5763398 Sprayable aqueous solution for drug delivery yields uniform plasma levels of the desmopressin peptide
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023619A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
06/04/1998WO1998023613A1 Fused bicyclic pyrimidine derivatives
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183291A 治疗前列腺疾病的康舒药物 Drug treatment of prostate disease Glands
06/03/1998CN1183285A Pill for treatment nephritis
06/03/1998CN1038586C Process for preparing pyrazine derivs
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760061 Using a benzothiophene compound
06/02/1998US5760060 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
06/02/1998US5760054 Alpha IC adrenergic receptor antagonists
06/02/1998US5760051 Central nervous system
06/02/1998US5760025 Administering testosterone 5a-reductase inhibitors
06/02/1998US5760014 Administering a blend of dextrose, dextrin, maltodextrin or mixtures with starches
05/1998
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998DE19649460A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0843553A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
05/27/1998EP0843551A1 Endothelin receptor antagonists
05/27/1998CN1182734A Imidaxolyl-substituted cyclohexane derivant
05/27/1998CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
05/26/1998US5756818 Hydrogenation; protecting; deprotecting; clathrates
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756473 6-O-methyl erythromycin D and process for making
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 562